Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07371091Not Yet Recruiting

Post-market Clinical Investigation Plan: Collagen Dura Regeneration Membrane - Repair (DMR)

Role: lead

NCT04775537Recruiting

OssiMend BA in Posterolateral Instrumented Lumbar Fusion

Role: lead

NCT06802133Recruiting

Post-Market Clinical Investigation Plan- Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus)

Role: lead

NCT07217132Not Yet Recruiting

Clinical Investigation Plan - Post-market Clinical Follow-up Study Collagen Dura Membrane - Suturable

Role: lead

NCT06822920Recruiting

Post-Market Clinical Investigation Plan - Collagen Dura Membranes (DM & DMO)

Role: lead

NCT05371535Not ApplicableUnknown

A Clinical Trial to Evaluate the Safety and Effectiveness of MatrixOssTM Bone Graft

Role: lead

NCT04851847Not ApplicableUnknown

A Clinical Trial to Evaluate the Safety and Effectiveness of Resorbable Collagen Membrane - MatrixflexTM

Role: lead

NCT03613090Phase 2Withdrawn

Novel Collagen Scaffold vs Conventional Scaffold in Regeneration of Human Dental Pulp Tissue

Role: collaborator

All 8 trials loaded